⌘K

Login Start Free

Home/Filings/4/A/0001127602-24-021890

4/A//SEC Filing

Green Eric Mark 4/A

Accession 0001127602-24-021890

CIK 0000105770other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:13 PM ET

Size

22.4 KB

Accession

0001127602-24-021890

Insider Transaction Report

Form 4/AAmended

Period: 2024-05-07

WEST PHARMACEUTICAL SERVICES INCWST

Green Eric Mark

DirectorPresident, CEO and Board Chair

Transactions

Exercise/Conversion
Common Stock
2024-05-07$59.64/sh+9,000$536,760→ 161,908.125 total
Exercise/Conversion
Common Stock
2024-05-07$59.64/sh+41,000$2,445,240→ 218,908.125 total
Exercise/Conversion
Common Stock
2024-05-07$57.38/sh+15,684$899,948→ 177,908.125 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-07−9,316→ 0 total
Exercise: $57.38From: 2015-04-24Exp: 2025-04-24→ Common Stock (9,316 underlying)
Sale
Common Stock
2024-05-07$366.64/sh−9,316$3,415,636→ 209,952.125 total
Sale
Common Stock
2024-05-07$366.66/sh−15,684$5,750,678→ 193,908.125 total
Sale
Common Stock
2024-05-07$366.65/sh−41,000$15,032,736→ 152,908.125 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-07−41,000→ 45,732 total
Exercise: $59.64From: 2017-02-23Exp: 2026-02-23→ Common Stock (41,000 underlying)
Exercise/Conversion
Common Stock
2024-05-07$57.38/sh+9,316$534,552→ 162,224.125 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-07−15,684→ 0 total
Exercise: $57.38From: 2016-02-23Exp: 2025-04-24→ Common Stock (15,684 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-05-07−9,000→ 36,732 total
Exercise: $59.64From: 2017-02-23Exp: 2026-02-23→ Common Stock (9,000 underlying)

Footnotes (2)

[F1]The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in either 2025 or 2026, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.
[F2]The price reported in Column 4 is a weighted average price.

Documents

1 file

4
form4a.xml
PRIMARY DOCUMENT

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1

filerCIK 0001336007

Filing Metadata

Form type: 4/A
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 4:13 PM ET
Size: 22.4 KB

View on SEC.gov